
AGENDA – Saturday, September 13, 2025
LOCATION: New York Marriott Marquis, 5th Floor Ballroom
7:15 am
Registration / Continental Breakfast
New York Marriott Marquis, 5th Floor7:55 am
Welcome and Introduction
Prakash Krishnan, MD8:00 am
Antiplatelet and Antithrombotic Therapy in PAD / CLTI
Marc P. Bonaca, MDSESSION I | CRITICAL LIMB ISCHEMIA I
8:15 am
LIVE CASE PRESENTATION #6: SESSIONS IN CLTI
Broadcast From: Cardiovascular Institute of the South, Houma, LAOperator:
8:45 am
Crossing Techniques for BTK CTO: Trans-Collateral, Subintimal, Direct Tibial Access, Retrograde Techniques (CART, Reverse CART)
Arthur C. Lee, MD8:55 am
How Does Lesion Morphology Affect My Access, Catheter, Wire Choice for Crossing BTK CTO Lesion?
Tatsuya Nakama, MD9:05 am
Role of Atherectomy in BTK Lesion: My Algorithm
Fadi A. Saab, MD9:15 am
When Do I Chose IVL Over Atherectomy in BTK Lesion?
Marianne Brodmann, MD9:25 am
BREAK / VISIT EXHIBITS
SESSION II | CRITICAL LIMB ISCHEMIA II
9:45 am
LIVE CASE PRESENTATION #7: SESSIONS IN CLTI: ANTEGRADE TIBIAL REVASCULARIZATION OF SEVERE TIBIAL DISEASE / CTO
Broadcast From: Arnsberg Vascular Center, Arnsberg, GermanyOperator:
10:15 am
Best-CLI, BASIL, BASIL-2: What Did I Learn?
TBD10:25 am
LIFE–BTK Study: 2-Year Results
Sahil A. Parikh, MD10:35 am
Role of Coronary Stents in BTK Lesions
Kumar Madassery, MD10:45 am
When Do I Choose Bypass vs. Endo in BTK Disease?
Yann Gouëffic, MD, PhD10:55 am
What’s On the Horizon for BTK Interventions?
Eric A. Secemsky, MD11:05 am
Panel Discussion / Q&A
SESSION III | CRITICAL LIMB ISCHEMIA III
11:25 am
LIVE CASE PRESENTATION #8: SESSIONS IN CLTI: MULTI-TIBIAL ARTERY REVASCULARIZATION
Broadcast From: Cardiovascular Institute of the South, Houma, LAOperator:
11:55 am
ALI Management: Case-Based Discussion (CDT Overnight vs. On-Table CDT vs. Device Embolic vs. Thrombotic)
Alfio Carroccio, MD12:05 pm
Pros and Cons of Available Thrombectomy Devices: How Do I Choose?
Brian G. DeRubertis, MD12:15 pm
Open Thrombectomy: Is There a Role, When and Why?
Eric Ducasse, MD, PhD12:25 pm
Case-Based Discussion
Srini Tummala, MD12:35 pm
ADJOURN CME SESSION / PICK UP LUNCH / VISIT EXHIBITS
1:05 pm -
1:45 pm
1:45 pm
LUNCH SYMPOSIUM – Sponsored by Abbott – Not CME Accredited
Bioresorbable Technology in Below-the-Knee Intervention: A Game-Changer in Management of CLTI: LIFE-BTK and REVA MedicalSESSION IV | CLTI MANAGEMENT
2:15 pm
Perfusion Assessment: All I Need to Know
Fabrizio Fanelli, MD2:25 pm
Access Techniques in Complex CLTI Cases (Case-Based Review)
Eric Ducasse, MD, PhD2:35 pm
Is There a Role of Pedal Arch Reconstruction in Today’s CLI World?
Arthur C. Lee, MD2:45 pm
DVA: Patient Selection and Where Does It Fit in My CLTI Practice?
Steven Kum, MD2:55 pm
My Personal Algorithm of When and How to Vessel Prep in BTK Disease
Craig M. Walker, MDSESSION V | RENAL DENERVATION
3:05 pm
Case Selection, Workup and Post-Procedure Follow-Up
Omar Al Dhaybi, MD3:15 pm
Renal Stenting in 2025: Is There a Role for Hypertension?
Robert A. Lookstein, MD3:25 pm
Renal Denervation: Update for 2025
Deepak L. Bhatt, MD3:35 pm
Available Devices: Pros and Cons of Each Device and How Do I Choose?
Andrew SP Sharp, MBChB, MD3:45 pm
Beth Israel Experience of Renal Denervation
Eric A. Secemsky, MD3:55 pm
BREAK / VISIT EXHIBITS
SESSION VI | CAROTID DISEASE
4:15 pm
Asymptomatic Carotid Stenosis: Should I Intervene?
Elizabeth Genovese, MD4:25 pm
Trans-Femoral vs. TCAR vs. CEA: How Do I Choose? Does It Matter?
Christian Bianchi, MD4:35 pm
Has the PERFORMANCE II Data Changed the Trans-Femoral Stenting Device Choice? What Is It and Data, etc.?
Ravish Sachar, MD4:45 pm
Panel Discussion / Q&A
SESSION VII | EXTREME INTERVENTIONS: MY GREAT VICTORIES
5:05 pm
Case 1: Kumar Madassery, MD
5:15 pm
Case 2: Steven Kum, MD
5:25 pm
Case 3: Nicolas Mouawad, MD
5:35 pm
Closing Remarks
Prakash Krishnan, MD5:40 pm